Business TechPfizer, Allergan Considering Blockbuster Merger: Combined Company Would Have $332B Market Cap Pfizer reportedly approached Allergan about a possible merger, which would create a company with a market cap of $332 billion. The takeover, if it pushes through, would be the biggest one for the year.by Aaron Mamiit
Healthy Living/WellnessUniversities And Colleges To Boost Meningitis B Vaccination effortsby Dianne Depra
Healthy Living/WellnessCDC Committee Pushes For Meningococcal Group B Vaccination For Adolescents And Young Adultsby Ted Ranosa
Healthy Living/WellnessPfizer Ibrance Breast Cancer Drug Shows Promising Results During Clinical Trialby Sumit Passary
Healthy Living/WellnessVaccine Costs in Developing Countries Too High, Many Blame GSK, Pfizerby James Maynard
Healthy Living/WellnessBetting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatmentby Rhodi Lee
Healthy Living/WellnessPfizer drug Xalkori effective against rare lung cancer in clinical trialby Christian Bautista
Healthy Living/WellnessPfizer's breast cancer drug Palbociclib slows down tumor growth, shows hope for advanced casesby Rhodi Lee
Healthy Living/WellnessNew experimental cholesterol drug by Amgen may be better than Lipitorby Rhodi Lee
'Pokémon Winds & Waves' Starter Evolution Debate: Fans Argue If Final Forms Are Becoming Too Humanoid
Why the Razer Blade 14 Leads Thin Gaming Laptops with Premium Build, Advanced Vapor Cooling, and Mercury White Style
iPadOS Stage Manager Unlocks Powerful Multitasking, External Display Support, and Smart Window Management